ScienceRise: Medical Science https://journals.uran.ua/sr_med <p style="font-weight: 400;"><em>"ScienceRise: Medical Science" </em>is a peer-reviewed scientific journal published 4 times a year.</p> <p style="font-weight: 400;">ScienceRise: Medical Science primarily publishes original research and clinical cases, but also accepts high-quality literature reviews and meta-analyses for publication. Short notices, short reviews, reports and messages are not published in the journal.</p> <p style="font-weight: 400;">The subject matter of the journal covers the areas of research devoted to treatment technologies, in particular, under conditions when the possibilities of decision-making regarding the treatment strategy are limited by insufficient sampling of diagnostic data, conditions for conducting long-term studies of chronic processes, the absence of conditions that would allow obtaining a sufficient volume of data sampling to determine adequate and effective treatment strategy. Related diagnostic problems are also considered.</p> <p style="font-weight: 400;">The journal is accredited by the Ministry of Health of Ukraine in the field of medical sciences and is recommended for publishing the results of dissertation research. <a href="http://nfv.ukrintei.ua/view/5b1925e37847426a2d0ab7e7">Included in the "B" category of the "List of Professional Publications of Ukraine"</a> (order of the Ministry of Education and Culture of Ukraine No. 612 of 07.05.2019).</p> <p>Registration of an entity in the media sector: Decision of the National Council of Ukraine on Television and Radio Broadcasting No. 695 dated August 10, 2023, protocol No. 17 (media identifier R30-01132).</p> <p style="font-weight: 400;">The journal is international, accredited by CrossRef and COPE and indexed by world resources of scientific periodicals.</p> <p><a href="https://portal.issn.org/resource/ISSN/2519-478X">ISSN 2519-478X</a>, <a href="https://portal.issn.org/resource/ISSN/2519-4798ISSN">E-ISSN 2519-4798</a>, <a href="https://portal.issn.org/resource/ISSN/2519-478X">ISSN-L 2519-478X</a><br /><br />Drawing up the items of the publication ethics policy of the journal «ScienceRise: Medical Science» Editors followed the recommendations of Committee on Publication Ethics <a href="http://publicationethics.org/">(COPE)</a>.</p> en-US <p>Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.</p> <p>Authors, who are published in this journal, agree to the following conditions:</p> <p>1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.</p> <p> 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.</p> med@entc.com.ua (Yuliia Nikolaieva) med@entc.com.ua (Yuliia Nikolaieva) Wed, 17 Dec 2025 22:15:35 +0200 OJS 3.2.1.2 http://blogs.law.harvard.edu/tech/rss 60 Endoscopic forehead lift in combination with botulinum therapy and fillers: analysis of efficacy and safety https://journals.uran.ua/sr_med/article/view/346733 <p><strong>The aim: </strong>Upper facial aging significantly impacts self-perception and quality of life as changes become apparent in the forehead, glabellar complex, and brow positioning. This narrative literature review evaluates clinical efficacy, safety profile and aesthetic outcomes of 3 treatment options: endoscopic forehead lift, botulinum toxin A and hyaluronic acid injectable dermal fillers, examining their individual and combined applications.</p> <p><strong>Materials and methods: </strong>Literature was obtained between April and August 2025 from electronic databases: PubMed, ScienceDirect, Google Scholar, Nature, Wiley Online Library, ResearchGate, Springer and Clinical key; using targeted search strategies. Inclusion criteria encompassed articles discussing these interventions in human participants published between 2000-2025. Exclusion criteria included mid-/lower face procedures, animal studies and non-peer reviewed editorials. Forty-one sources were selected based on clinical relevance and methodological quality.</p> <p><strong>Results: </strong>Endoscopic forehead lift demonstrated 93% patient satisfaction with superior long term structural repositioning. BoNT-A provided effective dynamic wrinkle reduction lasting 3-6 months with minimal complications. Hyaluronic acid fillers addressed volumetric deficits and static wrinkles lasting 6-18 months. Combined BoNT-A with HA fillers showed significantly enhanced outcomes, with 84.15% patient satisfaction at 6 months versus 55.12% with botulinum toxin A monotherapy. All modalities demonstrated excellent safety profiles with complications under 3%.</p> <p><strong>Conclusions: </strong>Multimodal rejuvenation addressing multiple aging mechanisms simultaneously results in superior aesthetic outcomes and patient satisfaction compared to single modality procedures. Substantial evidence gaps exist regarding optimal sequencing and long-term outcomes of combined surgical-injectable approaches. Future prospective studies examining endoscopic procedures with injectable modalities across diverse populations are essential to establish evidence-based clinical protocols</p> Nelli Pankovets Copyright (c) 2025 Nelli Pankovets http://creativecommons.org/licenses/by/4.0 https://journals.uran.ua/sr_med/article/view/346733 Wed, 17 Dec 2025 00:00:00 +0200